Develops the iTOF, the first wireless quantitative train-of-four (TOF) monitor controlled via mobile devices, integrating digital microelectronics for precise neuromuscular blockade assessment. This system reduces medication usage by 30%, decreases post-operative complications by 70%, and improves operating room efficiency by 10%, offering a cost-effective subscription model with a full replacement warranty.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Accurate monitoring of neuromuscular blockade is crucial during surgical procedures, but traditional methods can be cumbersome, inconsistent, and may not provide quantitative data, potentially leading to over- or under-dosing of neuromuscular blocking agents. Inadequate monitoring can result in residual neuromuscular blockade, increasing the risk of post-operative complications and prolonged recovery times.
Solution
Nerbio offers the iTOF, a wireless, app-controlled quantitative neuromuscular transmission monitor designed to improve the safety and efficiency of neuromuscular blockade management. The iTOF system consists of a Bluetooth-connected stimulator device and a mobile application that provides precise, automated, and quantitative monitoring of neuromuscular block levels. By delivering real-time data and AI-assisted training, iTOF enables clinicians to optimize medication usage, reduce post-operative complications, and enhance operating room throughput. The system's portability and ease of use facilitate consistent monitoring across various clinical settings, from pediatric to geriatric patients.
Target Audience
The primary target audience includes anesthesiologists, surgeons, and hospital administrators seeking to improve patient safety, reduce costs, and enhance operating room efficiency through precise neuromuscular blockade monitoring.
Features
- Wireless, Bluetooth-enabled connection between the iTOF device and iOS/Android mobile application
- Quantitative measurement of Train-of-Four (TOF) ratio and Double Burst Stimulation (DBS)
- Remote monitoring capabilities for enhanced caregiver safety
- AI-assisted training module for optimized usage and interpretation of results
- FDA-cleared for neuromuscular blockade monitoring
- Low-cost subscription model with a full replacement warranty
- Integration with EHR systems